Pacing for hypertrophic obstructive cardiomyopathy does it work?

ACC/AHA/NASPE, 2002. Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices – Full Text A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Implantation). Circulation 106, 2145–2161. Cooley, 1976, Mitral valve replacement for idiopathic hypertrophic subaortic stenosis: results in 27 patients, J. Cardiovasc. Surg. (Torino), 17, 380 Fananapazir, 1992, Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy, Circulation, 85, 2149, 10.1161/01.CIR.85.6.2149 Frank, 1978, Longterm medical management of hypertrophic obstructive cardiomyopathy, Am. J. Cardiol., 42, 993, 10.1016/0002-9149(78)90687-2 Jeanrenaud, 1992, Effects of dual chamber pacing in hypertrophic obstructive cardiomyopathy, Lancet, 339, 1318, 10.1016/0140-6736(92)91961-7 McIntosh, 1988, Current operative treatment of obstructive hypertrophic cardiomyopathy, Circulation, 78, 487, 10.1161/01.CIR.78.3.487 McKenna, 2002, Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death, Heart, 87, 169, 10.1136/heart.87.2.169 McKenna, 1981, Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features, Am. J. Cardiol., 47, 532, 10.1016/0002-9149(81)90535-X Bonow, 1981, Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy, Circulation, 64, 787, 10.1161/01.CIR.64.4.787 McDonald, 1988, Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy, Eur. Heart J., 9, 893, 10.1093/oxfordjournals.eurheartj.a062584